CadrevsJohnson & Johnson

CDRE and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

CDRE

Cadre Holdings, Inc.

$32.13

Value $1.4B

-3.86%
CDRE's page

Cadre (CDRE) has a market value of $1.4B and Johnson & Johnson (JNJ) $685B. Over the last year, with dividends, CDRE moved -24.3% and JNJ +48.4%. The P/E is 33.4 for CDRE and 42.6 for JNJ. Dividend yield: CDRE 1.24%, JNJ 1.86%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CDRE$1.4B

    JNJ$685B

    JNJ is 499 times CDRE

  • Revenue, 12 months

    CDRE$733M

    JNJ$99.3B

    JNJ is 136 times CDRE

  • Net income, 12 months

    CDRE$41M

    JNJ$16.1B

    JNJ is 392 times CDRE

  • Operating margin

    CDRE10.8%

    JNJ–

  • ROIC

    CDRE7.7%

    JNJ12.4%

    4.7 points apart

  • P/E

    CDRE33.4

    JNJ42.6

    JNJ is 1.3 times CDRE

  • Dividend yield

    CDRE1.2%

    JNJ1.9%

    0.7 points apart

  • 5-year return

    CDRE+57.7%

    JNJ+99.9%

    42.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CDRE+57.7%

JNJ+99.9%

10015020020222023202420252026
Returns by period
PeriodCDREWith dividendsJNJWith dividends
1 year since November 14, 2025-24.3%Price -25.2%+48.4%Price +45.1%
3 years since November 16, 2023+4.5%+1.5% a yearPrice +1.1%+106.3%+27.3% a yearPrice +89.4%
5 years since November 15, 2021+57.7%+9.5% a yearPrice +48.0%+99.9%+14.9% a yearPrice +73.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CDRECadreJNJJohnson & Johnson

Valuation

CDREJNJ
Valuation
Price$32.13$284.35
Market value$1.4B$685B
Enterprise value (EV)$1.7B$713B
P/E33.442.6
P/E, 5-year median38.021.9
P/B3.78.4
EV/EBIT21.340.2
Free cash flow yield5.6%3.0%

Results and growth

CDREJNJ
Results and growth
Revenue, 12 months$733M$99.3B
Net income, 12 months$41M$16.1B
Free cash flow, 12 months$76M$20.6B
Earnings per share, 12 months$0.91$6.59
Revenue growth, year on year7.5%6.1%
Revenue growth a year, past+8.6%over 5 years+2.7%over 5 years
EPS growth a year, past-6.1%over 5 years+14.9%over 5 years

Margins and returns on capital

CDREJNJ
Margins and returns on capital
Gross margin42.0%67.6%
Operating margin10.8%–
Net margin5.6%16.2%
ROIC7.7%12.4%
ROE12.0%19.7%

Balance sheet

CDREJNJ
Balance sheet
Cash$64M$17.2B
Total debt$394M$44.7B
Net debt / EBITDA3.11.1
Interest cover–18.0×

Dividends and buybacks

CDREJNJ
Dividends and buybacks
Dividend yield1.2%1.9%
Dividend per share, 12 months$0.40$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield–0.9%
Shareholder yield1.2%2.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CDRE or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Cadre or Johnson & Johnson?

By market value, Johnson & Johnson ($685B) is about 499.2 times Cadre ($1.4B), at today's prices.

How did CDRE and JNJ stock do over the last 5 years?

Since November 15, 2021, CDRE's price moved +48.0% and JNJ's +73.9%. With dividends: CDRE +57.7% (+9.5% a year), JNJ +99.9% (+14.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, CDRE or JNJ?

The dividend yield at today's price is 1.24% for Cadre and 1.86% for Johnson & Johnson. Over the last twelve months they paid $0.40 and $5.28 per share.

What is the P/E of CDRE and JNJ?

At today's price, the P/E is 33.4 for CDRE and 42.6 for JNJ. The median of the last five years was 38.0 and 21.9, which shows where each stands against its own past.

Which has the higher profit margins, Cadre or Johnson & Johnson?

Over the last twelve months, the net margin was 5.6% for Cadre and 16.2% for Johnson & Johnson, and the operating margin 10.8% and –. Revenue was $733M and $99.3B.

Which is the better investment, Cadre or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.